Viewing Study NCT01947959


Ignite Creation Date: 2025-12-24 @ 2:41 PM
Ignite Modification Date: 2026-01-01 @ 1:06 PM
Study NCT ID: NCT01947959
Status: COMPLETED
Last Update Posted: 2021-10-22
First Post: 2013-09-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Germany)
Sponsor: Bayer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module